Samil PharmaceuticalLtd Crescita futura

Future criteri di controllo 0/6

Al momento non disponiamo di una copertura analitica sufficiente per prevedere la crescita e il fatturato di Samil PharmaceuticalLtd.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Pharmaceuticals crescita degli utili	33.3%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	Low
Ultimo aggiornamento	05 Jun 2024

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Some Samil Pharmaceutical Co.,Ltd (KRX:000520) Shareholders Look For Exit As Shares Take 27% Pounding

Nov 18

Optimistic Investors Push Samil Pharmaceutical Co.,Ltd (KRX:000520) Shares Up 29% But Growth Is Lacking

Sep 13

We Think Samil PharmaceuticalLtd (KRX:000520) Is Taking Some Risk With Its Debt

Sep 11

Investor Optimism Abounds Samil Pharmaceutical Co.,Ltd (KRX:000520) But Growth Is Lacking

Jul 29

Does Samil PharmaceuticalLtd (KRX:000520) Have A Healthy Balance Sheet?

May 24

There's Reason For Concern Over Samil Pharmaceutical Co.,Ltd's (KRX:000520) Massive 29% Price Jump

Mar 30

Samil PharmaceuticalLtd's (KRX:000520) Earnings Are Of Questionable Quality

Mar 21

Here's Why Samil PharmaceuticalLtd (KRX:000520) Has A Meaningful Debt Burden

Apr 01

Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 141% Total Return On Their Investment

Mar 11

Are Dividend Investors Getting More Than They Bargained For With Samil Pharmaceutical Co.,Ltd's (KRX:000520) Dividend?

Feb 15

Should You Be Concerned About Samil Pharmaceutical Co.,Ltd's (KRX:000520) ROE?

Jan 20

Why It Might Not Make Sense To Buy Samil Pharmaceutical Co.,Ltd (KRX:000520) For Its Upcoming Dividend

Dec 24

Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 221% Total Return On Their Investment

Dec 09

What Is The Ownership Structure Like For Samil Pharmaceutical Co.,Ltd (KRX:000520)?

Nov 18

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché Samil PharmaceuticalLtd non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

KOSE:A000520 - Stime future degli analisti e dati finanziari passati (KRW Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2024	248,200	N/A	N/A	N/A	1
9/30/2024	212,424	-1,174	1,892	23,068	N/A
6/30/2024	210,733	-1,155	-7,882	15,330	N/A
3/31/2024	204,905	-786	-14,971	8,629	N/A
12/31/2023	196,346	1,664	-12,590	11,746	N/A
9/30/2023	189,293	2,600	-18,707	-43,369	N/A
6/30/2023	183,060	1,336	-28,155	-12,562	N/A
3/31/2023	179,566	343	-33,560	3,887	N/A
12/31/2022	179,676	-28	-44,502	4,154	N/A
9/30/2022	170,510	-4,989	-53,802	41,099	N/A
6/30/2022	158,910	-4,740	-40,593	15,161	N/A
3/31/2022	147,877	-5,619	-34,933	1,437	N/A
12/31/2021	134,247	-5,347	-31,194	1,417	N/A
9/30/2021	129,974	-2,761	-24,913	-1,229	N/A
6/30/2021	127,287	-1,327	-20,164	119	N/A
3/31/2021	122,793	132	-20,038	4,736	N/A
12/31/2020	122,999	1,341	-9,436	7,775	N/A
9/30/2020	123,114	940	2,747	15,430	N/A
6/30/2020	122,308	729	-9,557	11,450	N/A
3/31/2020	123,102	1,429	2,486	16,455	N/A
12/31/2019	121,107	786	-3,729	10,590	N/A
9/30/2019	114,364	-1,251	-13,267	40	N/A
6/30/2019	107,856	-3,368	-5	4,677	N/A
3/31/2019	102,805	-6,461	-7,234	-2,305	N/A
12/31/2018	94,600	-8,563	-6,538	-2,622	N/A
9/30/2018	96,882	-5,165	-2,899	1,319	N/A
6/30/2018	94,916	-4,605	N/A	2,217	N/A
3/31/2018	92,286	-2,797	N/A	3,258	N/A
12/31/2017	92,038	-1,267	N/A	3,791	N/A
9/30/2017	90,658	-1,434	N/A	-680	N/A
6/30/2017	92,118	898	N/A	1,539	N/A
3/31/2017	94,685	948	N/A	5,206	N/A
12/31/2016	96,758	887	N/A	5,634	N/A
9/30/2016	94,010	306	N/A	9,953	N/A
6/30/2016	92,625	140	N/A	5,840	N/A
3/31/2016	88,656	553	N/A	1,357	N/A
12/31/2015	88,136	588	N/A	2,920	N/A
9/30/2015	85,795	-2,986	N/A	-1,492	N/A
6/30/2015	85,439	-6,170	N/A	-4,921	N/A
3/31/2015	85,849	-10,179	N/A	-11,314	N/A
12/31/2014	85,461	-11,190	N/A	-11,923	N/A
9/30/2014	87,683	1,148	N/A	-12,731	N/A
6/30/2014	87,545	3,601	N/A	-6,621	N/A
3/31/2014	89,207	7,191	N/A	-586	N/A
12/31/2013	89,229	7,930	N/A	-3,990	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista A000520 è superiore al tasso di risparmio ( 2.7% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di A000520 cresceranno più velocemente del mercato KR

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di A000520 cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Dati insufficienti per determinare se si prevede che i ricavi di A000520 cresceranno più rapidamente del mercato KR.

Ricavi ad alta crescita: Dati insufficienti per determinare se si prevede che i ricavi di A000520 cresceranno più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di A000520 è previsto essere elevato tra 3 anni

Samil PharmaceuticalLtd Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Recent updates

Third quarter 2024 earnings released: ₩39.00 loss per share (vs ₩46.00 loss in 3Q 2023)

New major risk - Revenue and earnings growth

Some Samil Pharmaceutical Co.,Ltd (KRX:000520) Shareholders Look For Exit As Shares Take 27% Pounding

Optimistic Investors Push Samil Pharmaceutical Co.,Ltd (KRX:000520) Shares Up 29% But Growth Is Lacking

We Think Samil PharmaceuticalLtd (KRX:000520) Is Taking Some Risk With Its Debt

New minor risk - Share price stability

Investor Optimism Abounds Samil Pharmaceutical Co.,Ltd (KRX:000520) But Growth Is Lacking

Does Samil PharmaceuticalLtd (KRX:000520) Have A Healthy Balance Sheet?

First quarter 2024 earnings released: ₩118 loss per share (vs ₩55.00 profit in 1Q 2023)

There's Reason For Concern Over Samil Pharmaceutical Co.,Ltd's (KRX:000520) Massive 29% Price Jump

Samil PharmaceuticalLtd's (KRX:000520) Earnings Are Of Questionable Quality

Full year 2023 earnings released: EPS: ₩116 (vs ₩2.00 loss in FY 2022)

Investor sentiment deteriorates as stock falls 20%

Investor sentiment improves as stock rises 24%

New minor risk - Shareholder dilution

First quarter 2023 earnings released: EPS: ₩55.00 (vs ₩27.00 in 1Q 2022)

Full year 2022 earnings released: ₩2.00 loss per share (vs ₩425 loss in FY 2021)

Upcoming dividend of ₩80.00 per share

Samil Pharmaceutical Co.,Ltd announced that it has received KRW 4 billion in funding

Samil Pharmaceutical Co.,Ltd announced that it expects to receive KRW 5 billion in funding

First quarter 2022 earnings released: EPS: ₩27.00 (vs ₩49.00 in 1Q 2021)

Upcoming dividend of ₩75.00 per share

Samil Pharmaceutical Co.,Ltd announced that it has received KRW 35 billion in funding from a group of investors

Samil Pharmaceutical Co.,Ltd announced that it expects to receive KRW 35 billion in funding from a group of investors

Samil Pharmaceutical Co.,Ltd (KOSE:A000520) announces an Equity Buyback for KRW 500 million worth of its shares.

Here's Why Samil PharmaceuticalLtd (KRX:000520) Has A Meaningful Debt Burden

Full year 2020 earnings released: EPS ₩219 (vs ₩129 in FY 2019)

Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 141% Total Return On Their Investment

Samil Pharmaceutical Co.,Ltd, Annual General Meeting, Mar 19, 2021

Are Dividend Investors Getting More Than They Bargained For With Samil Pharmaceutical Co.,Ltd's (KRX:000520) Dividend?

New 90-day low: ₩19,950

Should You Be Concerned About Samil Pharmaceutical Co.,Ltd's (KRX:000520) ROE?

New 90-day low: ₩20,050

Why It Might Not Make Sense To Buy Samil Pharmaceutical Co.,Ltd (KRX:000520) For Its Upcoming Dividend

Upcoming Dividend of ₩150 Per Share

Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 221% Total Return On Their Investment

New 90-day low: ₩20,300

What Is The Ownership Structure Like For Samil Pharmaceutical Co.,Ltd (KRX:000520)?

Third quarter 2020 earnings released: ₩39.00 loss per share

New 90-day high - ₩24,400

New 90-day high - ₩23,650

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita